首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Hypofractionated stereotactic body radiation therapy for adrenal metastases
【24h】

Hypofractionated stereotactic body radiation therapy for adrenal metastases

机译:肾上腺转移次数的低分亢进的静态体辐射治疗

获取原文
获取原文并翻译 | 示例
       

摘要

Adrenal glands are a common site for metastatic spread since they represent the fourth metastatic site of solid tumors. Interest in local ablative treatments of oligometastases is growing since literature suggests better progression-free survival, quality of life and potentially overall survival in selected patients. Surgery remains the first treatment of adrenal oligometastases because results are good, with a long enough follow-up. However, stereotactic radiotherapy appears to be comparable to surgery and could be proposed to elderly, unfit, inoperable patients, or even to patients whose systemic treatment should not be suspended for too long. This article aims to present a review of published studies to date on stereotactic radiotherapy of adrenal metastases and to propose a treatment protocol. (c) 2017 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
机译:肾上腺是一种用于转移扩散的常见部位,因为它们代表了固体瘤的第四转移性位点。 由于文献提出了更好的无进展的存活,所选患者的生命质量和潜在的整体生存,因此对局部偏离寡聚菌的兴趣生长增长。 手术仍然是第一次治疗肾上腺素寡粒体,因为结果很好,足够长的随访。 然而,立体定向放射疗法似乎与手术相当,并且可以提出老年人,不合适,无法操作的患者,甚至不应暂停系统治疗的患者。 本文旨在审查迄今为止肾上腺转移的立体定向放射治疗和提出治疗方案的研究。 (c)2017 Societe Francaise de Radiotherapie Oncologique(SFRO)。 由Elsevier Masson SA出版。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号